ADAR1 Capital Management »

Neumora Therapeutics shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Neumora Therapeutics (NMRA) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $26k 26k 1.00
2024-12-31 $727k 69k 10.60

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Keros Therapeutics (KROS)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Immunovant (IMVT)
89bio (ETNB)
Zai Lab Adr (ZLAB)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Uniqure Nv SHS (QURE)
Prothena Corp SHS (PRTA)
Bridgebio Pharma (BBIO)
Arbutus Biopharma (ABUS)

View all positions for ADAR1 Capital Management

Top funds holding Neumora Therapeutics

Softbank Group Corp
MIC Capital Management UK
Siren
Vanguard Group
FMR
Wellcome Trust Limited, as Trustee of the Wellcome Trust
ICONIQ Capital
Lunate Capital
Millennium Management
T. Rowe Price Investment Management
Johnson & Johnson
BlackRock
Tang Capital Management
Renaissance Technologies
Two Sigma Advisers

View all funds holding Neumora Therapeutics